12
Nov
Lord's Mark Biotech, a subsidiary of Lord's Mark Industries, has introduced Tinefcon, a patented medicine for treating Psoriasis. Lord's Mark Biotech has signed an exclusivity agreement with INVEX Health Pvt Ltd for a patented product developed by Piramal life sciences in India, Tinefcon, which is being launched as a total solution for Psoriasis in four forms, priced between Rs. 799 - Rs. 3900. Lord's Mark Biotech, the exclusive distributor for Tinefcon, is utilizing a scientific sales force and a robust social media campaign to promote the product's Psoriasis solution, and will also offer it on internet marketplaces for patient recommendation.…
